Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent
- 1 November 2016
- journal article
- research article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 64 (5), 1311-1319
- https://doi.org/10.1016/j.jvs.2016.05.066
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Drug Delivering Technology for Endovascular Management of Infrainguinal Peripheral Artery DiseaseJACC: Cardiovascular Interventions, 2014
- German Multicenter Real-World Registry of Stenting for Superficial Femoral Artery Disease: Clinical Results and Predictive Factors for RevascularizationJournal of Endovascular Therapy, 2014
- Biological responses in stented arteriesCardiovascular Research, 2013
- Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary StentsCirculation, 2012
- Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?European Heart Journal, 2012
- Quantitative assessment of the conformational change in the femoropopliteal artery with leg movementCatheterization and Cardiovascular Interventions, 2009
- Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trialThe Lancet, 2007
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJournal of the American College of Cardiology, 2005
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseThe New England Journal of Medicine, 1994